• Publications
  • Influence
Tacrolimus: a further update of its use in the management of organ transplantation.
UNLABELLED Extensive clinical use has confirmed that tacrolimus (Prograf) is a key option for immunosuppression after transplantation. In large, prospective, randomised, multicentre trials in adultsExpand
  • 360
  • 13
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
UNLABELLED Tacrolimus (FK-506) is an immunosuppressant agent that acts by a variety of different mechanisms which include inhibition of calcineurin. It is used as a therapeutic alternative toExpand
  • 288
  • 10
Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
UNLABELLED Cyclosporin is a lipophilic cyclic polypeptide immunosuppressant that interferes with the activity of T cells chiefly via calcineurin inhibition. The original oil-based oral formulation ofExpand
  • 257
  • 8
Nelfinavir: an update on its use in HIV infection.
UNLABELLED Nelfinavir is one of several currently available protease inhibitors used to limit viral replication and improve immune function in HIV-infected individuals. It is administered inExpand
  • 115
  • 8
Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.
UNLABELLED Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor and nonstimulant that has shown greater efficacy than placebo in attention deficit hyperactivity disorder (ADHD) inExpand
  • 98
  • 8
Tocilizumab: a review of its use in the management of rheumatoid arthritis.
Tocilizumab (RoActemra or Actemra) is a recombinant humanized monoclonal antibody that acts as an interleukin (IL)-6 receptor antagonist. Intravenous tocilizumab 8 mg/kg (and no less than 4.8 mg), inExpand
  • 123
  • 8
Dapagliflozin: a review of its use in type 2 diabetes mellitus.
Dapagliflozin (Forxiga®) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) inhibitors and is used in the treatment of patients with type 2Expand
  • 70
  • 8
Amisulpride: a review of its use in the management of schizophrenia.
Amisulpride (Solian), a substituted benzamide derivative, is a second-generation antipsychotic that preferentially binds to dopamine D2/D3 receptors in limbic rather than striatal structures. HighExpand
  • 98
  • 7
Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.
Tenofovir disoproxil fumarate (tenofovir DF; Viread), an ester prodrug of the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir, is indicated in combination with other antiretroviral agentsExpand
  • 50
  • 7
Olanzapine: an updated review of its use in the management of schizophrenia.
UNLABELLED Olanzapine, a thienobenzodiazepine derivative, is a second generation (atypical) antipsychotic agent which has proven efficacy against the positive and negative symptoms of schizophrenia.Expand
  • 167
  • 6